High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

NCT00381953 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Interferon alfa-2a
DRUG: Ribavirin

Sponsor

Foundation for Liver Research